Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials

Wait 5 sec.

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.